%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
#us stocks
Stock analysis posts tagged "us stocks" from Openbook.
SoFi Stock Analysis: What the Latest SOFI Results Mean for Investors
SoFi's Q3 2026 beat and a first 2027 outlook of about $6.4bn revenue and $0.90 adjusted EPS lifted the shares 13.42% to $16.40. The Openbook read.
Super Micro Fundamental Analysis: SMCI Revenue, Margins, Debt and Valuation
Super Micro pre-announced September-quarter revenue $4bn above its guidance at $18.5bn-$19.5bn, with gross margin lifted to 12%-12.5%. Figures are unaudited.
IBM Stock Fundamentals 2026: IBM Earnings, Cash Flow and Valuation
IBM raised full-year free cash flow guidance above $1bn of growth but held revenue guidance at 4%-5%, as Q3 revenue rose 5% to $17.1bn on Software strength.
Danaher Stock Analysis: What the Latest DHR Results Mean for Investors
Danaher beat on Q3 adjusted EPS at $2.11 and raised full-year guidance, but core growth was 3.0% against 5.5% excluding the respiratory testing drag.
What Drives Intel (INTC) Shares: Fabs, x86 and Foundry Customers
Intel stock analysis for 2026: INTC grew revenue 25% in Q2 while posting an $11bn loss. Inside the products business, Foundry losses and balance sheet.
A Closer Look at Linde (LIN) Shares: Pipelines and Cylinders
A Linde stock analysis covering how LIN earns money from on-site, merchant and packaged gases, plus margins, backlog, dividend and the risks to watch.
Breaking Down GE Vernova (GEV) Shares: The Electricity Supply Chain
GE Vernova (GEV) stock analysis: record orders, a USD 176 billion backlog and what the Power, Electrification and Wind segments show in 2026.
UnitedHealth Group (UNH) Fundamentals: Insurance and Care Delivery
This UnitedHealth stock analysis breaks down the Q2 2026 numbers, the medical care ratio, and how the Optum and UnitedHealthcare margins moved.
Wells Fargo (WFC) Stock Analysis: Branches, Cards and Markets
Wells Fargo stock analysis: how its four segments earn revenue and what the latest reported quarter showed. Plus what lifting the asset cap changed.
Is Nike Stock a Good Investment in 2026? NKE Fundamentals Explained
Nike guided FY2027 revenue to fall high single digits and unveiled a USD 2.5bn Pace restructuring. What the five factors say at a twelve-year low.
Is Synopsys a Good Long-Term Investment? SNPS Growth, Profitability and Risks
Synopsys guided FY2027 revenue to a USD 11.15bn midpoint and signed AWS and OpenAI deals, lifting the shares 13%. Our read on the five factors.
Accenture Stock Analysis: What the Latest ACN Results Mean for Investors
Record USD 84.5bn full-year bookings and an above-consensus FY2027 guide drove Accenture's best single-day gain on record. We read the five factors.
General Mills Fundamental Analysis: GIS Revenue, Margins, Debt and Valuation
Grain costs up 17.7% and packaging rising: General Mills held organic sales flat but lost 11% of adjusted operating profit to the input-cost squeeze.
Lennar Stock Fundamentals 2026: LEN Earnings, Cash Flow and Valuation
Lennar's gross margin fell to 15.8% from 17.5% while incentives were cut to 12.0% of price, the clearest sign new-home margin pressure is structural.
IonQ Stock Analysis 2026: IONQ Share Price, Earnings and Outlook
IonQ ran a real-time quantum error decoder on a single CPU across 408 logical qubits. The shares opened near USD 46 and closed at USD 42.54.
Inside Goldman Sachs (GS) Shares: Advisory, Trading and Fee Income
Goldman Sachs stock analysis: how GS earns money across advisory, trading and asset management, what Q2 2026 reported, and the capital and cycle risks.
How Merck (MRK) Makes Its Money: Oncology and Vaccine Fundamentals
A Merck stock analysis of where MRK earns its revenue across oncology, vaccines and animal health, and what the 2028 Keytruda patent expiry changes.
Inside Cisco Systems (CSCO) Shares: Switches, Routers and Software
A Cisco stock analysis built on the FY2026 numbers. Revenue reached $63.3 billion, up 12%, while product gross margin fell. Here is what drives the business and what to watch next.
Lam Research (LRCX) Fundamentals: Etch, Deposition and Service
A Lam Research stock analysis of the etch and deposition maker: fiscal 2026 results, its installed-base service business, and the risks to watch.
Breaking Down Netflix (NFLX) Shares: Subscriptions and Ad Breaks
A Netflix stock analysis of the streaming business: Q2 2026 revenue, margins, the advertising build-out, free cash flow and what to watch from here.
A Closer Look at Palantir (PLTR) Shares: Defense and Enterprise
A Palantir stock analysis grounded in the Q2 2026 results: 93 percent revenue growth, the US government and commercial split, margins, cash and dilution.
Moderna (MRNA) Stock Analysis: The Melanoma Data and the Numbers
A Moderna stock analysis after the 177 percent move: what the INTerpath-001 melanoma readout disclosed, Q2 2026 revenue and losses, and the cash runway.
GE Aerospace (GE) Fundamentals: Engines, Spares and Overhauls
A GE Aerospace stock analysis covering how the engine maker earns from spare parts and overhauls, its Q2 2026 results and raised guidance, and the backlog, margin mix and risks worth tracking.
Inside AbbVie (ABBV) Shares: Immunology, Neuroscience and Botox
This AbbVie stock analysis breaks down Q2 2026 results, the Skyrizi and Rinvoq franchises that replaced Humira, margins, the dividend and key risks.
How Home Depot (HD) Makes Its Money: Aisles and Job Sites
A Home Depot stock analysis of the business behind the orange aprons: 2,359 stores, the SRS and GMS distribution deals, and what Q1 fiscal 2026 showed.
Inside Costco Wholesale (COST) Shares: Membership Fee Economics
Costco stock analysis: how membership fees, an 11% gross margin and steady warehouse openings shape what COST actually reports each quarter.
Oracle (ORCL) Fundamentals: Databases, ERP and Cloud Capacity
An Oracle stock analysis grounded in fiscal 2026 results: $67.4bn revenue, a $638bn contracted backlog and $55.7bn of capex. What the numbers show and what to watch.
What Drives Procter and Gamble (PG) Shares: Laundry to Diapers
A Procter and Gamble (PG) stock analysis grounded in the fiscal 2026 results: organic sales, margins, the dividend record and the fiscal 2027 cost headwinds worth watching.